MedPath

Evaluation of the effectiveness of high flow oxygen delivery through the nasal cannula in comparison with non-invasive ventilation in patients with COVID-19

Not Applicable
Conditions
COVID-19.
Coronavirus infection, unspecified
B34.2
Registration Number
IRCT20160516027929N8
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Arterial blood oxygen saturation less than 90%
Signing a written consent to participate in the study
Age over 18 years

Exclusion Criteria

Pulmonary insufficiency
Acute or chronic renal failure
Pregnancy or breastfeeding
Acute heart failure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Partial pressure of carbon dioxide. Timepoint: Before the intervention, 24 hours after the intervention and 48 hours after the intervention. Method of measurement: Through blood sampling and blood gas analysis.
Secondary Outcome Measures
NameTimeMethod
Oxygen saturation. Timepoint: Before the intervention, 24 hours after the intervention and 48 hours after the intervention. Method of measurement: Through blood sampling and blood gas analysis.
© Copyright 2025. All Rights Reserved by MedPath